Therapy for Patients with Previously Treated Metastatic Colorectal Cancer (mCRC)

INDICATION

STIVARGA is indicated for the treatment of patients with mCRC who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.

AUGUST 5th @7PM

Don't miss this virtual event!

Register via the following link: https:// tallen.adobeconnect.com/bay0000605/ event/registration.html